Alimera Sciences Data Available for the 11th Annual Congress on Controversies in Ophthalmology: Europe Virtual Conference

    NEXT STORY
    Cassava Sciences Announces Initiation of an Open-Label Study to Evaluate PTI-125 in Patients with Alzheimer’s Disease
    PREV STORY
    Neuromodulation Devices Market to Hit USD 9.34 Billion by 2026; Increasing Patient Population Worldwide to Feed Market Expansion: Fortune Business Insights™
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Relypsa Announces FDA Approval of Supplemental New Drug Application to Enable the Usage of Veltassa® (patiromer) With or Without Food

    author_avatar
    NASDAQ Market News

    resTORbio Announces Formation of Clinical Advisory Board

    Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead ...

    author_avatar
    NASDAQ Market News

    VBL Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference on September 26th in New York

    TEL AVIV, Israel, Sept. 14, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (NASDAQ:VBLT),  a clinical-stage ...

    author_avatar
    NASDAQ Market News